TA Associates Makes Strategic Growth Investment in HealthMark Group
July 30, 2025
TA Associates has made a strategic growth investment in HealthMark Group, a Dallas-based provider of clinical information exchange solutions. Management and existing investor Ridgemont Equity Partners rolled meaningful stakes as TA becomes the new lead investor to accelerate HealthMark's growth, expand capabilities, and broaden market reach.
- Buyers
- TA Associates
- Targets
- HealthMark Group
- Sellers
- Ridgemont Equity Partners
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
TA Associates Completes Strategic Growth Investment in Vee Healthtek
November 18, 2024
Healthcare Services
TA Associates completed a strategic growth investment in Vee Healthtek to support the company's expansion of technology-enabled services for healthcare organizations. The partnership will help Vee Healthtek enhance its technology capabilities, expand offerings (organically and via M&A) across revenue cycle management, health information management, analytics, risk adjustment and claims management; financial terms were not disclosed.
-
Hg and TA Associates Make Strategic Investment in The Access Group
October 20, 2020
Software
The Access Group, a UK-based provider of business management software, secured a substantial strategic investment from its two largest shareholders, Hg and TA Associates, who will retain joint control alongside the management team. The transaction (terms undisclosed) is intended to accelerate The Access Group's organic and acquisitive growth and support geographic expansion.
-
TA Associates Makes Growth Investment in Intelerad; Hg and ST6 Continue Support
July 14, 2022
Healthcare Services
TA Associates has signed a definitive agreement to make a growth investment in Intelerad, joining majority investor Hg and minority investor ST6. The capital will support Intelerad’s expansion of its enterprise medical imaging platform and accelerate product and go-to-market growth to serve hospitals, radiology groups and outpatient imaging centers.
-
TA Associates Makes Strategic Growth Investment in Caprock
September 28, 2021
Wealth Management
TA Associates has signed a definitive agreement to make a strategic growth investment in Caprock, a privately owned multi-family office. Financial terms were not disclosed; TA will partner with Caprock to scale the firm's platform and solution set, and TA principals Clara Jackson and Roy Burns will join Caprock's board.
-
TA Associates Makes Strategic Minority Investment in Kline Hill Partners
April 29, 2025
Financial Services
TA Associates has agreed to make a strategic minority investment in Kline Hill Partners to support the firm’s continued growth and scale its team and technology platform. The partnership will deepen Kline Hill’s capabilities in the private equity secondaries and asset/wealth management markets; terms were not disclosed and the deal is expected to close in Q2 2025.
-
TA Associates Makes Strategic Growth Investment in Diatech Pharmacogenetics
April 26, 2023
Biotechnology
TA Associates has signed a definitive agreement to make a strategic growth investment in Diatech Pharmacogenetics, a Jesi, Italy–based developer and manufacturer of molecular diagnostics for precision oncology. Minority investor Alto Partners will fully exit while Diatech's founder and management retain majority ownership; the capital will support product development and international expansion.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.